/Companies

IntuitiveX

Seattle, US · Founded 2019 · Delaware corporation · 12 employees on LinkedIn

Find your way into IntuitiveX

Each arrow is one introduction. Sign up to fill in the first one.

651 people can intro you to Jeffrey

Ask Andy Sack to introduce you to Jeffrey Roh

You →Andy · together at Founders' Co-op →Jeffrey

Sign up to find every way you can get introduced to IntuitiveX

  • Your email: who you already know at IntuitiveX, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the IntuitiveX team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

IntuitiveX is a medical innovation and venture group focused on healthcare and medical technology, bringing together clinicians, scientific advisors, and IP and business specialists to develop and commercialize products. Its team spans orthopedic, spine, cardiology, and neurosurgery expertise alongside intellectual property strategy and investment support.

Founders & leadership

JRJeffrey Roh
Jeffrey RohChief Executive OfficerJeffrey Roh holds an MD, MBA, and MSc in Technology Management, with over 20 years of experience in medical device innovation and entrepreneurship. He co-founded and grew multiple healthcare companies including Advanced Biologics (acquired by Bioventus in 2014) and Carlsmed (which went public in 2025), developed spine surgery systems for Stryker following IP acquisition in 2009, and now serves as CEO of IntuitiveX, a medical innovation and venture group.
JH
Jun HongNamed on SEC filing
SR
Simon RobinsonMBA
AC
Andy ChoiNamed on SEC filing
MH
Mark HanNamed on SEC filing
CC
Charles ChangNamed on SEC filing
TS
Thomas ShinNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.2M disclosed across 1 of 3 rounds · 2019–2023

▶Undisclosed amountofferedFeb 2023 · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • John CiannameaExecutive Officer
  • Jeffrey RohExecutive Officer, Director
  • Gary LockeDirector
  • Andy ChoiDirector
  • John CroninDirector
  • Simon RobinsonExecutive Officer, Director
  • Mark HanExecutive Officer, Director
Minimum investment
$50K
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedMay 2020 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jun HongExecutive Officer
  • Simon RobinsonExecutive Officer
  • Jeffrey RohExecutive Officer, Director
  • Charles ChangDirector
  • Thomas ShinDirector
  • Mark HanExecutive Officer, Director
  • Andy ChoiDirector
Offering amount
$9.4M
Amount sold
$1.2M
Minimum investment
$100K
Proceeds to insiders
$750K
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJun 2019 · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jun HongExecutive Officer
  • Simon RobinsonExecutive Officer
  • Jeffrey RohExecutive Officer, Director
  • Andy ChoiDirector
  • Mark HanExecutive Officer, Director
  • Charles ChangDirector
  • Thomas ShinDirector
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as IntuitiveX.

Frequently asked questions

What does IntuitiveX do?
IntuitiveX is a medical innovation and venture group focused on healthcare and medical technology, bringing together clinicians, scientific advisors, and IP and business specialists to develop and commercialize products. Its team spans orthopedic, spine, cardiology, and neurosurgery expertise alongside intellectual property strategy and investment support.
How much funding has IntuitiveX raised?
IntuitiveX has disclosed $1.2M raised across 1 of its 3 known rounds.
Where is IntuitiveX headquartered?
IntuitiveX is headquartered in Seattle, US.